1.广西中医药大学研究生院 南宁 530200
2.广西中医药大学第一附属医院
3.河南中医药大学第一附属医院
李蕾蕾,女,在读博士生
# 韦艾凌,男,博士,教授,主任医师,博士生导师,主要研究方向:中医药防治慢性肝病,E-mail: wal33@163.com
纸质出版日期:2023-07-30,
网络出版日期:2023-05-26,
收稿日期:2022-12-22,
移动端阅览
李蕾蕾, 韦艾凌, 张永琴, 等. 从脏腑、气血津液、形神探讨原发性肝癌的防治思路[J]. 北京中医药大学学报, 2023,46(7):1020-1024.
LI Leilei, WEI Ailing, ZHANG Yongqin, et al. Prevention and treatment of primary liver cancer based on zang-fu, qi, blood, body fluids, body and mind[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023,46(7):1020-1024.
李蕾蕾, 韦艾凌, 张永琴, 等. 从脏腑、气血津液、形神探讨原发性肝癌的防治思路[J]. 北京中医药大学学报, 2023,46(7):1020-1024. DOI: 10.3969/j.issn.1006-2157.2023.07.021.
LI Leilei, WEI Ailing, ZHANG Yongqin, et al. Prevention and treatment of primary liver cancer based on zang-fu, qi, blood, body fluids, body and mind[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023,46(7):1020-1024. DOI: 10.3969/j.issn.1006-2157.2023.07.021.
肝为生机之主使,是维持机体健康的重要屏障。癥瘕积聚为气血津液运化失常的产物,肝积是肝内癥瘕聚散消长变化的结果,脏腑、气血津液、癥瘕间的关联性是肝积形成的开端。肝积指停滞在肝体中凝结难消的有形癥积及处于持续化生、异变中的病变形式和病理状态,以气病为先,因聚散变化、正邪交争衍生而来。脏腑、气血津液、形神是中医辨证论治和整体调摄的对象,健运中土、充足肾气、养正除积以治脏腑;散无形邪气,消有形癥积,疏肝气、通滞结、抗癌毒以和气血;解郁结、和气血、安精神以济形神。
Liver is the master of vitality and an important barrier for maintaining good health. Abdominal masses are the products of abnormal transport and transformation of qi
blood
and body fluids. Masses in the liver are the results of the accumulation and dispersion of abdominal masses in the liver. The relationship among zang-fu
qi
blood
body fluids
and abdominal masses is the origin of masses in the liver. Masses in the liver refer to the tangible accumulation in the liver and a pathological form and state of the disease that is in the process of continuous metaplasia and mutation. Qi disease is the early lesion of masses in the liver
which derives from a change of accumulation and dispersion
and the conflict between healthy qi and pathogenic qi. Zang-fu
qi
blood
body fluids
body and mind are the carriers of traditional Chinese medicine syndrome differentiation and holistic health preservation. The main treatments are as follows: strengthening the spleen
supplementing kidney qi and reinforcing vital qi and removing stasis to treat zang-fu organs; dispelling intangible evil qi and tangible masses
soothing liver qi
removing stasis and cancer toxin to harmonize qi and blood; and removing stagnation
harmonizing qi and blood and calming the mind to coordinate body and mind.
原发性肝癌脏腑癥瘕肝积形神
primary liver cancerzang-fuabdominal massesmasses in the liverbody and mind
SHI JF, CAO MM, WANG YT,et al. Is it possible to halve the incidence of liver cancer in China by 2050?[J]. Int J Cancer,2021,148(5):1051-1065.
赫捷,陈万青,沈洪兵,等.中国人群肝癌筛查指南(2022,北京)[J].中国肿瘤,2022,31(8):587-631.
李瀚旻.论“肝主生发”的养生观[J].中华中医药学刊,2013,31(10):2085-2087.
刘小雨,王行宽.肝与血脉别论[J].中医杂志,2005,46(9):646-648.
于宁,翟双庆.《黄帝内经》之“肝主生发”[J].中华中医药杂志,2014,29(5):1291-1293.
李瀚旻.论“肝主生发”[J].中华中医药学刊,2009,27(10):2021-2025.
杜武勋,朱明丹,张斐,等.中医气化论与中药愈病机理探讨[J].中医杂志,2013,54(13):1081-1084.
周唯.调肝治百病探述[J].中医药学报,2009,37(2):3-5.
李蕾蕾,符宇,邵明义,等.从“气血津液-癥瘕积聚-脉积”探讨糖尿病合并冠心病防治思路[J].中国中医基础医学杂志,2021,27(10):1560-1563.
闻晓琳,程海波,李柳,等.理气解郁法防治早期恶性肿瘤的应用探析[J].中医杂志,2022,63(6):581-583.
北京中医医院.关幼波临床经验选[M].北京:人民卫生出版社,1979:216.
王永炎.关于提高脑血管疾病疗效难点的思考[J].中国中西医结合杂志,1997,17(4):195-196.
卢红蓉,杜松,胡镜清.痰瘀互结证治理论源流考[J].中医杂志,2015,56(10):811-815.
常富业,王永炎,李辉,等.《内经》毒论诠析[J].时珍国医国药,2007,18(11):2684-2685.
王书杰,张永琴,韦艾凌.浅论痰瘀在原发性肝癌发生、发展及转移中的作用[J].中国中医基础医学杂志,2012,18(9):957-958.
顾思纯,杨柏灿.癥瘕积聚的病证范围及治疗探析[J].江苏中医药,2017,49(9):11-13.
杜菲,陈明显,沈堂彪,等.朱丹溪“痰挟瘀血,遂成窠囊”学说的临证应用[J].浙江中医药大学学报,2021,45(6):633-636.
王书杰,韦艾凌.肝癌“湿热伏邪”:“癌毒”发病机制及疗法探讨[J].中国中西医结合杂志,2013,33(2):266-269.
PAROLA M, PINZANI M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinicalissues[J]. Mol Aspects Med,2019,65:37-55.
ZUNIGA-AGUILAR E, RAMIREZ-FERNANDEZ O. Fibrosis and hepatic regenerationmechanism[J/OL].Transl Gastroenterol Hepatol,2022,7:9[2022-06-28]. https://tgh.amegroups.com/article/view/5977.
HODLER J, KUBIK-HUCH RA, VON SCHULTHESS GK. Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic Imaging[M]. Cham:Springer, 2018:229-236.
SATO T, KONDO F, EBARA M, et al. Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study[J]. Hepatol Int, 2015,9(2):330-336.
刘瑞,花宝金,侯炜.从气机升降学说论肿瘤治则[J].北京中医药大学学报,2014,37(12):802-804.
刘瑞,李杰,张玉人.疏肝理气法防治肿瘤转移的作用及分子机制探讨[J].中医杂志,2012,53(10):886-890.
程海波.癌毒病机理论探讨[J].中医杂志,2014,55(20):1711-1715.
王书杰,韦艾凌,张永琴,等.癌痛消方调控大鼠移植性肝癌细胞Survivin及Bcl-2的实验研究[J].中国中西医结合杂志,2012,32(12):1652-1657.
黄覃凤,张永琴,梁丽英,等.癌痛消方对缺氧肝癌细胞血管生成拟态的影响[J].广西中医药,2021,44(5):77-80.
宋亚刚,白明,崔琳琳,等.基于数据发掘探寻肝癌中医临床用药的宏观规律[J].中国实验方剂学杂志,2021,27(13):146-152.
李要远,郑红刚,花宝金.运用扶正调气法论治肿瘤[J].中医杂志,2022,63(6):588-591.
田建辉,刘海涛,董昌盛,等.御神在肿瘤防治中的作用探析[J].中医杂志,2018,59(24):2093-2098.
朱广辉,李杰,王新苗.基于和法辨治肿瘤患者情志异常[J].中医杂志,2021,62(9):819-821.
0
浏览量
7
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构